New blood test could spot sepsis faster, saving lives and antibiotics
NCT ID NCT07203833
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking at whether a protein called vasorin (Vasn) in the blood can help doctors quickly tell the difference between septic shock (caused by infection) and other types of shock (like after heart surgery). Currently, the best test for this is not always accurate. The researchers will measure vasorin levels in 144 intensive care patients and see if it can better guide treatment decisions, such as whether antibiotics are needed. They will also check if vasorin levels can predict which patients are at higher risk of dying within 28 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOMARKER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens-Picardie
RECRUITINGAmiens, 80000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Aging in place: could mobile teams keep nursing home residents out of the hospital?
- Blood markers may foretell brain fog after sepsis
- Can tracking immune chaos in sepsis reveal new treatment targets?
- Can a simple risk calculator help catch prostate cancer earlier in nigerian men?
- Blood clot score may predict organ damage in septic shock
- Two-Week stool test may forecast ulcerative colitis Flare-Ups a year in advance